These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Utilizing minimally purified secreted rAAV for rapid and cost-effective manipulation of gene expression in the CNS. Goodwin MS; Croft CL; Futch HS; Ryu D; Ceballos-Diaz C; Liu X; Paterno G; Mejia C; Deng D; Menezes K; Londono L; Arjona K; Parianos M; Truong V; Rostonics E; Hernandez A; Boye SL; Boye SE; Levites Y; Cruz PE; Golde TE Mol Neurodegener; 2020 Mar; 15(1):15. PubMed ID: 32122372 [TBL] [Abstract][Full Text] [Related]
7. Quantifying transduction efficiencies of unmodified and tyrosine capsid mutant AAV vectors in vitro using two ocular cell lines. Ryals RC; Boye SL; Dinculescu A; Hauswirth WW; Boye SE Mol Vis; 2011 Apr; 17():1090-102. PubMed ID: 21552473 [TBL] [Abstract][Full Text] [Related]
8. Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction. Naumer M; Popa-Wagner R; Kleinschmidt JA J Gen Virol; 2012 Oct; 93(Pt 10):2131-2141. PubMed ID: 22764318 [TBL] [Abstract][Full Text] [Related]
9. Tropism of the Novel AAVBR1 Capsid Following Subretinal Delivery. Carroll L; Uehara H; Zhang X; Ambati B Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887086 [TBL] [Abstract][Full Text] [Related]
10. The use of melittin to enhance transgene expression mediated by recombinant adeno-associated virus serotype 2 vectors both in vitro and in vivo. Xie YL; Wang JY; He Y; Yu XM; Zheng QY; Ling C; Feng XL; Zhu LQ J Integr Med; 2023 Jan; 21(1):106-115. PubMed ID: 36333178 [TBL] [Abstract][Full Text] [Related]
11. Molecular Engineering of Adeno-Associated Virus Capsid Improves Its Therapeutic Gene Transfer in Murine Models of Hemophilia and Retinal Degeneration. Mary B; Maurya S; Kumar M; Bammidi S; Kumar V; Jayandharan GR Mol Pharm; 2019 Nov; 16(11):4738-4750. PubMed ID: 31596095 [TBL] [Abstract][Full Text] [Related]
15. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Burger C; Gorbatyuk OS; Velardo MJ; Peden CS; Williams P; Zolotukhin S; Reier PJ; Mandel RJ; Muzyczka N Mol Ther; 2004 Aug; 10(2):302-17. PubMed ID: 15294177 [TBL] [Abstract][Full Text] [Related]
16. Tolerability and tropism of recombinant adeno-associated virus vectors in the African green monkey (Chlorocebus sabaeus) anterior chamber. Chern KJ; Issac KZ; Gumbs ZD; O'Connor ME; Lawrence MS; Lipinski DM Gene Ther; 2023 Sep; 30(9):714-722. PubMed ID: 37221271 [TBL] [Abstract][Full Text] [Related]
17. Enhanced Transduction of P2X7-Expressing Cells with Recombinant rAAV Vectors. Mann AM; Schäfer W; Adriouch S; Börner K; Grimm D; Braren I; Koch-Nolte F Methods Mol Biol; 2022; 2510():129-144. PubMed ID: 35776323 [TBL] [Abstract][Full Text] [Related]
18. Different tropism of adenoviruses and adeno-associated viruses to corneal cells: implications for corneal gene therapy. Liu J; Saghizadeh M; Tuli SS; Kramerov AA; Lewin AS; Bloom DC; Hauswirth WW; Castro MG; Schultz GS; Ljubimov AV Mol Vis; 2008; 14():2087-96. PubMed ID: 19023450 [TBL] [Abstract][Full Text] [Related]